Anatomic Pathology Market by Product & Service - 2021

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021. The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables. Likewise, the services segment has been subsegmented into cytopathology, histopathology, and other services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

In the instrument subsegment, the tissue processing systems segment accounted for the largest share of the anatomic pathology market in 2016 due to the increasing automation in the instruments that improve the quality of diagnosis process. Similarly, in the consumables subsegment, the reagents & antibodies segment accounted for the largest share of the market, in 2016. This is due to increasing number of diagnostics tests that fuel the utilization of reagents & antibodies. Likewise, in the services subsegment, the histopathology segment accounted for the largest market share in 2016. This is mainly due to their use in the diagnosis of a wide range of chronic diseases, such as cancer, and bacterial and viral diseases.

Request PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=137323145

On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment accounted for the largest market share in 2016. The rapid growth in the aging population and increasing incidence of cancer and other chronic diseases is a key market driver in this segment. The drug discovery & development segment accounted for the second largest share in 2016. Increasing R&D expenditure is driving the adoption of anatomic pathology services in pharmaceutical and biopharmaceutical companies for drug discovery & development applications.

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates & forecasts and market share analysis.

Anatomic Pathology Market

On the basis of region, the global anatomic pathology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.

Some of the major players operating in the anatomic pathology market are F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Press Release : https://www.marketsandmarkets.com/PressReleases/anatomic-pathology.asp

Source : https://www.prnewswire.com/news-releases/anatomic-pathology-market-worth-219-billion-usd-by-2021-616725644.html

Pharmacy Automation Market by Product & End User - 2022

The global pharmacy automation market is segmented on the basis of product, end users and regions. The study also provides product portfolio assessment which compares offerings of major market players; value chain analysis; market penetration rate in various geographies; market dynamics; industry trends; and business strategy matrix for pharmacy automation market.
In 2016, automated medication dispensing systems accounted for the largest share of the pharmacy automation market. The factors such as improved medication safety, better inventory management, improved storage capacity with optimal utilization of space, and potential time and cost savings are the major drivers of market growth.

The inpatient pharmacies end user segment accounted for the largest share of pharmacy automation systems market. The increasing need for improved accuracy and efficiency of pharmacy units in hospitals and the growing need to minimize the waiting time in inpatient pharmacies are key market drivers in this end-user segment.

Request PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=71522890

The pharmacy automation market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 8.2% between 2017 and 2022 to reach USD 5.38 Billion by 2022. The growth in this market is mainly attributed to factors such as growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population, and rising labor cost.

Pharmacy Automation Market 

In 2016, North America accounted for the largest share of the global pharmacy automation market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the government regulations and initiatives, high adoption of pharmacy automation and the presence of major companies in this region. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. With the rapid rise in the number of patients, demand for quality care, effective upgradation of the healthcare IT infrastructure of the country is expected to have a positive impact on the demand for pharmacy automation systems.

Becton, Dickinson, and Company (U.S.), and Omnicell, Inc. (U.S.) held the major share of the pharmacy automation systems market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst Systems LLC. (U.S.).

Press Release : https://www.marketsandmarkets.com/PressReleases/pharmacy-automation-systems.asp

Source : https://www.prnewswire.com/news-releases/pharmacy-automation-market-worth-538-billion-usd-by-2022-620059903.html

Radiation Dose Management Market by Products, Services, Application & End User - 2022

The global market is segmented on the basis of products & services, modality, end user, and region. On the basis of products and services, the market is segmented into solutions and services. The solutions market is further subdivided into standalone solutions and integrated solutions. The services market is subdivided into implementation and integration services, support and maintenance services, consulting services, and education and training services. By modality, the market is divided into computed tomography, fluoroscopy and interventional imaging, radiography & mammography, and nuclear medicine. The market is further segmented by end users into hospitals, ambulatory care settings, and research institutions and academic medical centers.

Radiation Dose Management Market

Geographically, the global market is segmented into four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). In 2017, North America accounted for the largest share of the global radiation dose management market, followed by Europe, Asia-Pacific, and RoW. This is due to the presence of a large number of hospitals and health systems, changing regulations, increasing accreditation requirements, and the increasing need to curtail the soaring healthcare costs.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=82326344

However, the market in Europe is expected to grow at the highest CAGR during the forecast period. Government initiatives in this region to increase patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the European market. The EU directives regarding the use of ionizing radiation, which will be repealed from February 6, 2018, is a prime factor for the increasing adoption of radiation dose management solutions by healthcare providers in Europe, which in turn is driving the growth of this geographic segment during the next two years

The key players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.S.), PACSHealth LLC (U.S.), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.), Siemens Healthineers (Germany), AGFA Healthcare (Belgium), Sectra AB (Sweden), QAELUM N.V. (Belgium), Bracco Imaging S.p.A. (Italy), and Medsquare (France). Key players in the radiation dose management market are pursuing several organic and inorganic growth strategies such as product launches & upgrades, partnerships, collaborations & agreements, acquisitions, and expansions to garner larger shares in the market.

The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 Million by 2022 from USD 161.3 Million in 2017. This market is mainly driven by the increasing needs to cut radiation dose levels causing chronic diseases, need for regulatory compliance, and need for improved patient safety and for accurate and reliable systems to manage critical radiation dose levels and information. Moreover, the safe and ensured environment through radiation dose management systems results in a streamlined workflow, thus increasing the operational efficiency and quality of healthcare organizations. However, lack of funding and lack of standardized protocols for radiation dose management are expected to restrain the growth of this market to a certain extent in the developing regions.

Press Release : https://www.marketsandmarkets.com/PressReleases/radiation-dose-management.asp

Source : https://www.aboutpharma.com/blog/2017/05/10/radiation-dose-management-market-worth-931-3-million-usd-by-2022/

Computer Assisted Coding Market by Software, Service & Application - 2022

In 2016, the solutions segment dominated the product and service computer-assisted coding market. The solutions segment is subsegmented into standalone software and integrated software. The integrated computer-assisted coding software segment is the fastest-growing segment of the global computer-assisted coding solutions. This can be attributed to the growing need for optimized computer-assisted coding software for seamless workflow and successful data integration within healthcare provider systems.

Based on application, the market is categorized into three types automated computer-assisted encoding, management reporting and analytics, and clinical code auditing. The automated computer-assisted encoding segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to usage benefits such as the improvement in the quality of clinical-coded diagnosis and procedures encoding productivity of coders while ensuring better revenue capture through coding, decreased coding variability, and efficient problem documentation for quick review and maximization of the return on investment.

By mode of delivery, the global computer-assisted coding market is segmented into web-based solutions, cloud-based solutions, and on-premise solutions. In 2016, the web-based solutions segment dominated the global market. This growth can be attributed to the advantage of its flexible, scalable, and affordable nature and additional advantage of a separate cloud for the client along with a public cloud server and easy access to information for users operating in different time zones and geographic locations.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=170644018

The major end users of computer-assisted coding are healthcare providers and healthcare payers. The providers are further segmented into hospitals, physicians’ practices, clinical laboratories, academic medical centers, and other healthcare institutions. In 2016, the providers dominated the global computer-assisted coding market. This is primarily attributed to the significant demand for CAC solutions among hospitals and physicians/clinics for improving data accuracy and productivity, maximize hospital revenue by minimizing coding errors, and shortening the claims reimbursement cycle.

Geographically, the global computer-assisted coding market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, North America dominated the global market. The rising need to minimizing operational errors, thereby reducing healthcare costs, increasing government efforts toward strengthening the healthcare infrastructure through the implementation of healthcare IT solutions and improving the quality of care are driving the growth of the market in this region. Asia-Pacific is the fastest-growing market for computer-assisted coding. The growth of the global market across the Asia-Pacific region is primarily driven by the escalating demand to reduce the burden of the healthcare systems, curtail healthcare delivery costs, increasing implementation of healthcare IT solutions, and the various government initiatives for enabling efficient, affordable, and on-time delivery of quality care.

In 2016, 3M Company (U.S.) and Optum, Inc. (U.S.) dominated the global computer-assisted coding market. Some of the prominent players in the market are Nuance Communications, Inc. (U.S.), Cerner Corporation (U.S.) and Artificial Medical Intelligence, Inc. (U.S.). Some of the other leading players in this market are Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Streamline Health Solutions, Inc. (U.S.), MMODAL IP LLC (M*Modal) (U.S.), TruCode (U.S.), Quest Diagnostics Inc. (U.S.), and Epic Systems Corporation(U.S.).

The global computer-assisted coding market is projected to reach USD 4.75 Billion by 2022 at a CAGR of 11.5% during the forecast period. The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the rising demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures. However, high implementation and maintenance expenses for computer-assisted coding and lack of IT professionals in the healthcare industry are likely to hinder the growth of the market to some extent.

The computer-assisted coding market in this report is segmented on the basis of by product and service, application, mode of delivery, and end user. This report also provides market information on major regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World.

Press Release: https://www.marketsandmarkets.com/PressReleases/computer-assisted-coding.asp

Source : http://www.erienewsnow.com/story/36310043/computer-assisted-coding-market-worth-475-billion-usd-by-2022

Patient Engagement Solutions Market by Component, Delivery Mode, Applications & End User - 2022

The key factors driving the growth of this market include the rise in aging population, increasing burden of chronic diseases, and focus of patients on self-managing their care has led to an increase in the adoption of patient engagement solutions globally. However, in spite of the numerous benefits certain barriers such as security of patient data and lack of interoperability are restraining the growth of this market.

By component, the software segment accounted for the largest share of the market in 2017
On the basis of component, the patient engagement solutions market is broadly segmented into software, hardware, and services. In 2017, The software segment is estimated to account for the largest share of the global patient engagement solutions market. However, the market for the services (including services for consulting, storage, implementation of solutions, training, maintenance, and regular up gradation of technology) is expected to grow at the highest CAGR during the forecast period.

By delivery mode, the on-premise segment held the largest market share in 2017
On the basis of delivery mode, the patient engagement solutions market is further classified into on-premise and cloud-based models. In 2017, the on-premise delivery mode is expected to account for the largest share of the global patient engagement solutions market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=105975994

However, the cloud-based solutions market is projected to register the highest CAGR during the forecast period. The ability to access computing and storage resources swiftly when needed, without the requirement for a large technical staff, is one of the reasons that is driving the market growth of the cloud-based delivery mode.

By application, the health management segment held the largest market share in 2017
Based on application, the patient engagement solutions market is further segmented into health management, social and behavioral management, home health management, and financial health. In 2017, the health management segment is expected to account for the largest share and is expected to register the highest CAGR during the forecast period. Providers encouraging patients to adopt these tools as it saves a lot of time for the providers as well as increase patient compliance for care is the major factor driving the growth of this segment.

North America dominated the market in 2017
North America accounted for the largest share of the patient engagement solutions market in 2016, followed by Europe. Federal mandates’ focus on Meaningful Use of Healthcare IT, need to curb rising healthcare cost and reduce hospital readmissions, rising number of accountable care organizations (ACO) as end users for patient engagement platforms, rising aging population in the US and Canada’s efforts to enhance healthcare delivery and digital health measures in Canada will also drive market growth during the forecast period.

Patient Engagement Solutions Market

Factors such as growing demand for advanced healthcare solutions and efficient healthcare delivery in Germany, role of NHS in the UK, implementation of the Dossier Médical Personnel (DMP) in France, and rising number of initiatives to improve care coordination in RoE are expected to boost the adoption of patient engagement solutions in these countries.

The key players in the market include McKesson Corporation (US), Allscripts (US), IBM (US), athenahealth (US), Cerner Corporation (US), and Orion Health (New Zealand).

Mycoplasma Testing Market by Product & Services, Technique, Application and End User - 2022

Factors driving the growth of this market are the rapid growth in the pharmaceutical and biotechnology industries, R&D investments and government support. Mycoplasma testing is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the globe serves as a direct driver for associated markets such as mycoplasma testing.

Kits & reagent is expected to dominate the market in 2017

On the basis of products, the mycoplasma testing market is segmented into kits & reagents, instruments, and services. The kits & reagents segment is expected to dominate the global mycoplasma testing market in 2017. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques are key factors driving the growth of this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=136509856

PCR technique are estimated to command the largest market share in 2017

Based on technique, the mycoplasma testing market is segmented into PCR, ELISA, direct assays, indirect assays, DNA staining, microbial culture techniques, and enzymatic methods. In 2017, the PCR technique segment is expected to account for the largest share of the mycoplasma testing market, by technique. The high acceptance rate of PCR due to the accuracy, speed, and flexibility provided by this technique in life sciences research is one of the major factors driving this segment.

Mycoplasma Testing Market 

North America to account for the major market share in 2017

Based on region, the mycoplasma testing market is segmented into North America, Europe, Asia, and Rest of the World (RoW). North America is expected to dominate the mycoplasma testing market in 2017 on account of the high adoption rate of novel technologies and a large number of life science research studies conducted in this region.

Key players in the mycoplasma testing market include Thermo Fisher Scientific Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Lonza Group Ltd. (Switzerland), Merck KGaA (Germany), Roche Diagnostics (Switzerland), SGS S.A. (Switzerland), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.), InvivoGen (U.S.), PromoCell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd., WuXi AppTec (U.S.), Norgen Biotek Corp. (Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A (Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories (U.S.), GeneCopoeia, Inc. (U.S.), GenBio (Canada), Hylabs (Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc. (U.S.), Sartorius AG (Germany), Savyon Diagnostics (Israel), and ScienCell Research Laboratories, Inc. (Canada).

Source : https://www.prnewswire.com/news-releases/english-releases/mycoplasma-testing-market-worth-9434-million-usd-by-2022-628381673.html

The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

The key players in the glycomics market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

On the basis of application, the market is segmented into diagnostics, drug discovery & development, oncology, immunology, and other applications. In 2016, the drug discovery and development segment is expected to account for the largest share of the market. This growth can be attributed to increase in R&D activities for the development of novel drugs and therapies.

Factors such as increasing government and private funding for glycomics and proteomics research and growing R&D expenditure by pharmaceutical and biotechnology companies are the key drivers for the growth of the market. Whereas, the high degree of consolidation is expected to restrict the entry of new players in the market, and thereby hinder its growth.

On the basis of product, the market is segmented into enzymes, instruments, kits, and reagents. The enzymes segment is projected to grow at the highest CAGR during the forecast period. This growth is mainly attributed to their consumable nature and wide applications in a variety of R&D and drug discovery procedures. The enzymes segment is further divided into glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, and other enzymes.

Download PDF Bochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=132685525

On the basis of end user, the glycomics market is segmented into academic research institutes, pharmaceutical & biotechnology companies, and CROs. In 2016, the academic research institutes segment is projected to account for the largest share of the market. This growth can be attributed to the increasing government and private funding for proteomic and glycomics research.

glycomics market 

On the basis of region, the market is segmented into North America, Asia, Europe, and RoW. The Asian market is estimated to grow at the highest CAGR during the forecast period. This growth is mainly attributed to the increasing commercialization of R&D by pharmaceutical and biotechnology companies, growing demand for personalized medicine, and rising importance of companion diagnostics.

Gas Chromatography on rise As Increasing Crude & Shale Oil Production

The growth in this market is driven by factors such as increase in crude & shale oil production, increasing importance of waste water treatment, rising adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns, and increased importance of chromatography in drug testing.

The global Gas chromatography market USD 2.64 Billion in 2016.

In this report, the gas chromatography market is segmented on the basis of instruments, accessories and consumables, end users, and regions. The instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment is projected to register the highest CAGR during the forecast period. The growth of this segment can primarily be attributed to factors such as increased capability to analyze complex compounds and technological advancements.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=101656773

On the basis of accessories and consumables, the market is segmented into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, pressure regulators, gas generators, and other accessories. The columns segment is expected to be the fastest-growing of the global gas chromatography market during the forecast period. The growth of this segment can primarily be attributed to factors such as discovery of new oil fields and the availability of improved gas chromatography columns for the petroleum industry.

Gas Chromatography Market

On the basis of end users, the market is segmented into oil & gas industry, environmental agencies, food & beverage industry, pharmaceutical & biotechnology companies, academic & government institutes, and cosmetic industry. The environmental agencies segment is expected to register the highest CAGR in the forecast period. Various policies and initiatives to reduce environmental pollution levels and the increasing importance of waste water treatment are the major factors driving the growth of this end-user segment.

On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific, and the RoW. Of these, North America accounted for the largest market share in 2016. Factors such as increase in the U.S. shale gas production, growing funding for environmental testing and clean-up in Canada, increasing funding for R&D activities in healthcare & environmental industries, and growing food testing industries are driving the growth of the North American gas chromatography market.

Major players in this market include Agilent Technologies, Inc. (U.S), Thermo Fisher Scientific, Inc. (U.S), Shimadzu Corporation (Japan), PerkinElmer, Inc. (U.S), Danaher Corporation (U.S), Scion instruments (Techcomp USA Inc.), Leco corporation (U.S), Merck KgaA (Germany), Falcon Analytical Systems &Technology, LLC (U.S), Restek Corporation (U.S), Dani Instruments S.P.A. (Italy) and Chromatotec (France).

The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%. The growth in this market is driven by factors such as increase in crude & shale oil production, increasing importance of waste water treatment, rising adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns, and increased importance of chromatography in drug testing.

Asia-Pacific accounted for the largest share in Pharmaceutical Robots Market

The global pharmaceutical robots market is segmented on the basis of type, application, and region.

Based on type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016.

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market.

Pharmaceutical Robots Market

"Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, opportunities, and challenges.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=210985096

This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.

On the basis of application, the global pharmaceutical robots market is segmented into picking and packaging, inspection of pharmaceutical drugs, and laboratory applications. In 2016, the picking and packaging segment accounted for the largest share of the global pharmaceutical robots market. Factors such as demand for personalized packaging configurations and advantages of robots in pharmaceutical manufacturing such as high speed, accuracy, ability to track and trace, error-free operation, fewer accidents, and better utilization of the floor space are contributing to the large share of the picking and packaging segment.

Based on region, the pharmaceutical robots market is divided into North America, Europe, Asia-Pacific, and the Rest of the World. In 2016, Asia-Pacific accounted for the largest share of the global market. This segment is also projected to register the highest CAGR of 14.1% during the forecast period. Factors such as the increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy are driving the growth of the APAC pharmaceutical robots market.

Pharmacy Automation Market led by Becton, Dickinson, and Company (U.S.), and Omnicell, Inc. (U.S.)

Becton, Dickinson, and Company (U.S.), and Omnicell, Inc. (U.S.) held the major share of the pharmacy automation systems market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst Systems LLC. (U.S.).

The global pharmacy automation market is segmented on the basis of product, end users and regions. The study also provides product portfolio assessment which compares offerings of major market players; value chain analysis; market penetration rate in various geographies; market dynamics; industry trends; and business strategy matrix for pharmacy automation market.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownload.asp?id=71522890

"Pharmacy Automation Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022", The pharmacy automation market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 8.2% between 2017 and 2022 to reach USD 5.38 Billion by 2022. The growth in this market is mainly attributed to factors such as growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population, and rising labor cost.

In 2016, automated medication dispensing systems accounted for the largest share of the pharmacy automation market. The factors such as improved medication safety, better inventory management, improved storage capacity with optimal utilization of space, and potential time and cost savings are the major drivers of market growth.

Pharmacy Automation Market

The inpatient pharmacies end user segment accounted for the largest share of pharmacy automation systems market. The increasing need for improved accuracy and efficiency of pharmacy units in hospitals and the growing need to minimize the waiting time in inpatient pharmacies are key market drivers in this end-user segment.

In 2016, North America accounted for the largest share of the global pharmacy automation market, followed by Europe, Asia-Pacific, and RoW. Growth in the developed markets in North America and Europe is mainly driven by the government regulations and initiatives, high adoption of pharmacy automation and the presence of major companies in this region. Furthermore, growth in insurance coverage in the U.S. has increased the burden on the country’s healthcare system, which has highlighted the need for improving efficiency and management of work in North America. As opposed to the North American and European markets, the demand in the APAC and Latin American markets is primarily driven by the growth in the overall healthcare industry. With the rapid rise in the number of patients, demand for quality care, effective upgradation of the healthcare IT infrastructure of the country is expected to have a positive impact on the demand for pharmacy automation systems.

Overview of Global Healthcare IT Market

Over the years, the adoption of HCIT solutions has increased significantly, mainly due to factors such as rising healthcare costs, increasing demand for more efficient and interoperable systems, and the challenges faced by providers (such as patient management, managing Big Data and analytics, and security breaches).

Government compliance and regulatory issues also increase the burden on both providers and HCIT companies. These challenges, in turn, trickle down to payers and accountable care organizations (ACOs). HCIT solutions can help address these issues.

MarketsandMarkets helps HCIT companies understand the pain points and provide appropriate strategies to deal with them. The services provided by our HCIT consultants include:

Adoption Rate Analysis of Various Solutions
• End-user Perception Analysis
• Budget Analysis
• Competitive Scenario, Regulations, and Market Assessment

Published Reports:

 "Patient Engagement Solution Market "

Patient engagement solutions involve healthcare information technology (HCIT) solutions, associated hardware, and services that are typically used to engage patients in their own health. These platforms enable patient centric healthcare delivery to ensure value-based care and enhance health outcomes.

The patient engagement solutions market is projected to reach USD 18.68 Billion by 2022 from USD 7.49 Billion in 2016, at a CAGR of 16.2%.

For Details Information , Request Sample Report: "http://tinyurl.com/y7chbzv7"

Factors such as a rise in the aging population, increasing burden of chronic diseases and focus of patients on self-managing their care has led to an increase in the adoption of patient engagement solutions globally.

However, in spite of the numerous benefits certain barriers such as security of patient data and lack of interoperability are restraining the growth of this market. In this report, 2016 is considered as the base year and the forecast period is from 2017 to 2022.

"Healthcare IT Consulting Market "

 A number of factors such as growing digitization in healthcare, rapidly changing HCIT landscape, government support for healthcare IT solutions, growing HCIT expenditure, lack of skilled IT professionals in the healthcare industry, growing venture capital investments in health IT, and the need for data security are driving the growth of healthcare IT consulting market. On the other hand, end-user concerns regarding the confidentiality are restraining the growth of this market.

The global HCIT consulting services market is expected to reach USD 45.42 Billion by 2022 from USD 18.38 Billion in 2017, at a CAGR of 19.8%.

For Details Information , Request Sample Report: "http://tinyurl.com/yaqjd5jb"

"Computer Assisted Coding Market"

The growth of the market can be attributed to the transition to ICD-10 coding standards from ICD-9 in North America, the rising demand for CAC solutions, the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue cycle management procedures.

However, high implementation and maintenance expenses for computer-assisted coding and lack of IT professionals in the healthcare industry are likely to hinder the growth of the market to some extent.

The global computer-assisted coding market is projected to reach USD 4.75 Billion by 2022 at a CAGR of 11.5% during the forecast period.

For Details Information , Request Sample Report: "http://tinyurl.com/ycdo62fv"

In 2016, the solutions segment dominated the product and service computer-assisted coding market. The solutions segment is subsegmented into standalone software and integrated software.

The integrated computer-assisted coding software segment is the fastest-growing segment of the global computer-assisted coding solutions. This can be attributed to the growing need for optimized computer-assisted coding software for seamless workflow and successful data integration within healthcare provider systems.

Radiation Dose Management Market: Geographic Growth Opportunities

The key players in the radiation dose management market are Bayer AG (Germany), GE Healthcare (U.S.), PACSHealth LLC (U.S.), Philips Healthcare (Netherlands), Fujifilm Holdings Corporation (Japan), Novarad Corporation (U.S.), Siemens Healthineers (Germany), AGFA Healthcare (Belgium), Sectra AB (Sweden), QAELUM N.V. (Belgium), Bracco Imaging S.p.A. (Italy), and Medsquare (France). Key players in the radiation dose management market are pursuing several organic and inorganic growth strategies such as product launches & upgrades, partnerships, collaborations & agreements, acquisitions, and expansions to garner larger shares in the market.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=82326344

The market in Europe is expected to grow at the highest CAGR during the forecast period. Government initiatives in this region to increase patient safety and the need to improve overall efficiency in healthcare organizations are driving the growth of the European market. The EU directives regarding the use of ionizing radiation, which will be repealed from February 6, 2018, is a prime factor for the increasing adoption of radiation dose management solutions by healthcare providers in Europe, which in turn is driving the growth of this geographic segment during the next two years

The global radiation dose management market is estimated to grow at a CAGR of 42.0% from 2017 to 2022, to reach USD 931.3 Million by 2022 from USD 161.3 Million in 2017. This market is mainly driven by the increasing needs to cut radiation dose levels causing chronic diseases, need for regulatory compliance, and need for improved patient safety and for accurate and reliable systems to manage critical radiation dose levels and information. Moreover, the safe and ensured environment through radiation dose management systems results in a streamlined workflow, thus increasing the operational efficiency and quality of healthcare organizations.

Implementation of Incentives to Shift the Burden of Risk From Healthcare Payers to Providers

Based on application, the patient engagement solutions market is segmented into health management, home health management, social and behavioral management, and financial health management. In 2017, the health management applications segment is expected to account for the largest share of the global market. The large share of this segment can be attributed to the increasing awareness among patients about the complexity of their disease conditions and their willingness to actively participate in maintaining their own health.

Based on end user, the patient engagement solutions market is segmented into providers (hospitals and physicians), payers, patients, and other end users (employer groups, government bodies, and pharmaceutical companies). In 2017, the healthcare providers segment is estimated to account for the largest share of the global market. The large share of this segment can be attributed to the high demand for patient engagement solutions by healthcare providers in order to maintain a competitive edge in the market.

The global patient engagement solutions market USD 8.80 Billion in 2017, For More Information,
Request Sample Research Report : http://www.marketsandmarkets.com/pdfdownload.asp?id=105975994

In 2017, McKesson Corporation (US) and Cerner Corporation (US) were some of the major players in the global patient engagement solutions market. Some of the other players competing in the market are Allscripts (US), IBM (US), athenahealth (US), Orion Health (New Zealand), Getwell Network (US), Lincor Solutions (Ireland), Yourcare Universe (US), WelVU (US), Get Real Health (US), and Oneview Healthcare (Ireland).

Geographically, North America is estimated to account for the largest share of the global market, followed by Europe. The growth of the North American market is expected to be centered particularly in the US. Growth in this segment is largely driven by the federal mandates, focus on Meaningful Use of Healthcare IT, need to curb rising healthcare cost and reduce hospital readmissions

The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.

The key players :

Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan).

Request Sample Report : http://www.marketsandmarkets.com/pdfdownload.asp?id=210985096

In the coming years, The pharmaceutical robots market is expected to witness the highest growth in the Asia-Pacific region. This region accounted for the largest share of the market. This can be attributed to factors such as an increase in domestic industrial robot companies, flourishing pharmaceutical industry, increasing number of conferences and exhibitions, investment and funding in the robots industry, and Japan’s Robot Strategy.

Pharmaceutical Robots Market, by Type

Traditional Robots
• Articulated Robots
• SCARA (Selective Compliance Articulated Robot Arm) Robots
• Delta/Parallel Robots
• Cartesian Robots
• Other Robots (spherical robots and dual-arm robots)
• Collaborative Robots

Pharmaceutical Robots Market, by Application

• Picking and Packaging
• Inspection of Pharmaceutical Drugs
• Laboratory Applications 

Rising Incidence of Cancer Increased Importance of Anatomic Pathology Market

Geographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this market.

Request Sample Report : http://www.marketsandmarkets.com/pdfdownload.asp?id=137323145

Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

The anatomic pathology market was valued at USD 16.2 Billion in 2016 and poised to grow at a CAGR of 6.1% between 2016 and 2021, to reach USD 21.9 Billion in 2021. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The anatomic pathology market is witnessing high growth due to factors such as increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure.

Anatomic Pathology Market, by Product & Service
• Instruments
• Consumables
• Services

Anatomic Pathology Market, by Application
• Disease Diagnosis
• Drug Discovery & Development
• Other Applications 

Untapped emerging regions are expected to offer new growth opportunities in Laboratory Freezers Market

The increasing number of organs transplant procedures, growing demand for blood and blood components, and technological advancements in freezers and refrigerators are the key factors driving the growth of the laboratory freezers market. However, factors such as increasing use of refurbished equipment and intense pricing pressure on manufacturers are restraining the growth of this market.

Request Sample Report : http://www.marketsandmarkets.com/pdfdownload.asp?id=196600540

The global laboratory freezers market is consolidated in nature, with the top five companies accounting for a major market share in 2015. Some of the key players in this market are Thermo Fisher Scientific Inc. (U.S.), Haier Biomedical (China), Eppendorf AG (Germany), Helmer Scientific (U.S.), VWR Corporation (U.S.), ARCTIKO A/S (Europe), Biomedical Solutions Inc. (U.S.), EVERmed S.R.L. (Italy), Philipp Kirsch GmbH (Germany), and Panasonic Healthcare Co., Ltd. (Japan). The leading players in this market have a major focus on new product launches, agreements, collaborations, partnerships, and expansion of their geographic presence in emerging markets. These are the widely adopted strategies by leading players to enhance their revenue streams and achieve sustainable growth in this competitive market.

North America accounted for the largest share of the laboratory freezers market, followed by Europe. The growing awareness & adoption of advanced lab freezers & refrigerators, significant growth in the number of life sciences research activities for disease treatment, and growing R&D spending in pharmaceutical & biotechnology industries in the region are driving the growth of the North American market. The Asia-Pacific region, however, is expected to witness a higher growth in the coming years, primarily due to the improving healthcare infrastructure, rising awareness about technologically advanced devices, and growth in biotechnology research in this region. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging APAC countries.